Needles, Syringes, IV Access Market Research Reports & Industry Analysis
This issue has placed a premium on the development of new products designed to prevent accidental needle sticks, which spread blood-borne pathogens.
Medical supply manufacturers around the globe are trying to develop new safety and innovative products, including sharps safety medical devices to protect health care workers. The University of Virginia’s International Healthcare Worker Safety Center lists 12 companies offering retractable needles/syringes.
The products involve a variety of technologies, for example, a safety needle device has a needle encapsulation sleeve after it has been used; the sleeve automatically resheathes the needle and locks it so that it cannot be exposed.
Blunt safety devices deploy a two-needle system, one inside the other. The inside needle is hollow and has a flat, blunt end. The outside sharp needle is used to access the vein. The inner needle moves forward and past the sharp needle to insure safety before it is removed from the patient. Such devices are known as first-generation safety products.
The retractable syringe is a unique device requiring no change in the basic procedure of delivery of the medication by health care workers. Once the injection is complete, the needle safely retracts from the patient into the syringe barrel -- thus, there is no risk of accidental needle stick injuries that can transmit HIV, hepatitis, or other infections to health care workers. Retractable syringes are considered second generation safety products.
Needles, Syringes, IV Access Industry Research & Market Reports
-
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-Like Peptide-1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase) - Global Forecast to 2030
... age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role ... Read More
-
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2025-2033
... 2025-2033. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market. ... Read More
-
Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound Guided Biopsy, Stereotactic Guided Biopsy, MRI Guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Region 2025-2033
... The rising prevalence of cancer, increasing preference for personalized medicine, and the push toward minimally invasive procedures for patient comfort and quicker recovery times are some of the major factors propelling the market. Biopsy devices ... Read More
-
Global Intravenous (IV) Fluid Bags Market 2025-2029
... the intravenous (IV) fluid bags market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Injection Pens
... CAGR of 5.9% over the analysis period 2024-2030. Disposable Injection Pens, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the ... Read More
-
Disposable Syringes
... CAGR of 6.1% over the analysis period 2024-2030. Safety Syringes, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$15.0 Billion by the end of the analysis ... Read More
-
Retractable Needle Safety Syringes
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Automatic Retractable Needle Safety Syringes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$176.7 ... Read More
-
Sterile Injectable Drugs
... at a CAGR of 9.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$577.6 Billion by the end ... Read More
-
Intravenous Needles
... CAGR of 6.3% over the analysis period 2024-2030. Teflon Dispensing Needles, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.8 Billion by the end of the ... Read More
-
Acute Care Needleless Connectors
... 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Simple Needleless Connectors, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.2 Billion by ... Read More
-
Insulin Pen Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Standard Insulin Pen Needles, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the ... Read More
-
Biopsy Needles
... CAGR of 5.7% over the analysis period 2024-2030. Vacuum-Assisted Needles, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$971.8 Million by the end of the analysis ... Read More
-
Needle-Free IV Connectors
... at a CAGR of 8.5% over the analysis period 2024-2030. Positive Fluid Displacement Connectors, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$997.5 Million by the ... Read More
-
Prefilled Syringes
... CAGR of 8.6% over the analysis period 2024-2030. Single-Chamber Syringes, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$6.3 Billion by the end of the analysis ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Dental Syringes
... CAGR of 6.2% over the analysis period 2024-2030. Non-Disposable Syringes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$99.6 Million by the end of the analysis ... Read More
-
Disinfection Caps
... CAGR of 4.2% over the analysis period 2024-2030. Non-Retail Distributor, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$289.3 Million by the end of the analysis ... Read More
-
Special Purpose Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Hypodermic Needles, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$6.9 Billion by the end of ... Read More
-
Sharps Containers
... CAGR of 5.7% over the analysis period 2024-2030. Multipurpose Containers, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$352.8 Million by the end of the analysis ... Read More
-
Iron Drugs
... CAGR of 7.9% over the analysis period 2024-2030. Oral Drugs, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$6.7 Billion by the end of the analysis ... Read More
-
Needles
... 4.9% over the analysis period 2024-2030. Conventional Needles, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth ... Read More
-
Intravenous (IV) Solutions
... at a CAGR of 7.5% over the analysis period 2024-2030. Parenteral Nutrition, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$15.1 Billion by the end of ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end ... Read More
-
Wearable Injectors
... CAGR of 9.5% over the analysis period 2024-2030. On-Body Injectors, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Aspiration & Biopsy Needles
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Biopsy Needles, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the ... Read More
Research Assistance
